SCHEMBL7249663

SCHEMBL7249663

O=C1SC(c2cccc(F)c2)N(CCCI)C1=O

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.42
HPGD P15428 3/20 0.40
HTT P42858 2/20 0.40
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 3/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 2/20 0.39
GFER P55789 1/20 0.39
HTR7 P34969 4/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
RXFP1 Q9HBX9 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
POLB P06746 1/20 0.35
PKM P14618 1/20 0.35
BLM P54132 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7251855 0.87 ACHE (0.48) ACHEL3MBTL1HPGDHTTALDH1A1
SCHEMBL7249569 0.85 ACHE (0.48) ACHEHPGDHTTALDH1A1TSHR
SCHEMBL7255088 0.81 KMT2A (0.46) HTTALDH1A1KDM4EKMT2AMEN1
SCHEMBL7249425 0.79 ACHE (0.71) ACHEALDH1A1GFERHTR7KMT2A
SCHEMBL7257221 0.73 ACHE (0.49) ACHEHPGDHTTALDH1A1TSHR
SCHEMBL7249964 0.72 CACNA1B (0.45) HTTALDH1A1TSHRHTR7KMT2A
SCHEMBL7251754 0.68 KMT2A (0.48) HTTALDH1A1KDM4ETSHRKMT2A
SCHEMBL28484694 0.67 GFER (0.47) ACHEALDH1A1GFERHTR7KMT2A
SCHEMBL7248241 0.67 ACHE (0.41) ACHEKDM4EGFER
SCHEMBL7248243 0.67 ACHE (0.41) ACHEKDM4EGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506751-B1 The compounds are useful in the treatment and prevention of the AIDS virus. Intermediates useful in the preparation of the final products, pharmaceutical compositions containing the final products are also taught. invention is directed to MILLENNIUM PHARMACEUTICALS, INC. 2003-01-14 US disclosed